The client develops smart inhalers with preloaded therapeutic substances, designed for precise low-dose administration to reduce side effects by up to 90%. Initially tested at a regional hospital, they need a comprehensive digital ecosystem to enable real-time monitoring, tracking, and management of inhaler usage across a global user base. The primary challenges include establishing secure Bluetooth communication for sensitive healthcare data, ensuring high availability and scalability of the platform, and maintaining data integrity and security amid unreliable internet connectivity and varied device protocols.
A mid-sized medical technology company specializing in smart inhaler devices and digital health solutions aiming to expand globally.
The implementation of this secure, scalable digital platform will enable healthcare providers to efficiently monitor and manage inhaler devices globally, facilitate safe data handling of sensitive health information, and support rapid feature deployment through an agile development process. This will improve patient outcomes, streamline provider workflows, and position the company for successful global expansion, similar to achieving significant funding milestones through prototype validation and investor demonstration.